FNCH(FNCH)
FNCH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E |
|---|---|
| Revenue Avg | $345M |
| Low | $345M |
| High | $345M |
| EBITDA Avg | $-207M |
| Low | $-207M |
| High | $-207M |
| EBIT Avg | $-207M |
| Low | $-207M |
| High | $-207M |
| Net Income Avg | $86M |
| Low | $86M |
| High | $86M |
| EPS Avg | $53.40 |
| Low | $53.40 |
| High | $53.40 |
| Analysts (Rev / EPS) | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $5M | $650,000 | $650,000 | $750,000 | $400,000 | — | — | — |
| Low | $5M | $650,000 | $650,000 | $750,000 | $400,000 | — | — | — |
| High | $5M | $650,000 | $650,000 | $750,000 | $400,000 | — | — | — |
| EBITDA Avg | $-3M | $-390,000 | $-390,000 | $-450,000 | $-240,000 | — | — | — |
| Low | $-3M | $-390,000 | $-390,000 | $-450,000 | $-240,000 | — | — | — |
| High | $-3M | $-390,000 | $-390,000 | $-450,000 | $-240,000 | — | — | — |
| EBIT Avg | $-3M | $-390,000 | $-390,000 | $-450,000 | $-240,000 | — | — | — |
| Low | $-3M | $-390,000 | $-390,000 | $-450,000 | $-240,000 | — | — | — |
| High | $-3M | $-390,000 | $-390,000 | $-450,000 | $-240,000 | — | — | — |
| Net Income Avg | $-15M | $-21M | $-21M | $-20M | $-16M | $-4M | $-7M | $-9M |
| Low | $-15M | $-21M | $-21M | $-20M | $-16M | $-4M | $-7M | $-9M |
| High | $-15M | $-21M | $-21M | $-20M | $-16M | $-4M | $-7M | $-9M |
| EPS Avg | $-9.60 | $-12.90 | $-12.90 | $-12.60 | $-9.90 | $-2.70 | $-4.50 | $-5.67 |
| Low | $-9.60 | $-12.90 | $-12.90 | $-12.60 | $-9.90 | $-2.70 | $-4.50 | $-5.67 |
| High | $-9.60 | $-12.90 | $-12.90 | $-12.60 | $-9.90 | $-2.70 | $-4.50 | $-5.67 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | — / 1 | — / 1 | — / 1 |